| 1 |
Sun G, Lin CH, Mei G, Gu J, Fan SF, Liu X, Liu R, Liu XW, Chen XS, Zhou C, Yi X, Jin P, Chang CP, Lin XJ. Recovery of neurosurgical high-frequency electroporation injury in the canine brain can be accelerated by 7,8-dihydroxyflavone. Biomed Pharmacother 2023;160:114372. [PMID: 36773524 DOI: 10.1016/j.biopha.2023.114372] [Reference Citation Analysis]
|
| 2 |
Xu Z, Zhang G, Zhang X, Lei Y, Sun Y, He Y, Yang F, Nan W, Xing X, Li Y, Lin J. Menstrual blood-derived endometrial stem cells inhibit neuroinflammation by regulating microglia through the TLR4/MyD88/NLRP3/Casp1 pathway. Int J Biochem Cell Biol 2023;157:106386. [PMID: 36754162 DOI: 10.1016/j.biocel.2023.106386] [Reference Citation Analysis]
|
| 3 |
García-bonilla M, Ojeda-pérez B, Shumilov K, Rodríguez-pérez L, Domínguez-pinos D, Vitorica J, Jiménez S, Ramírez-lorca R, Echevarría M, Cárdenas-garcía C, Iglesias T, Gutiérrez A, Mcallister JP, Limbrick DD, Páez-gonzález P, Jiménez AJ. Generation of Periventricular Reactive Astrocytes Overexpressing Aquaporin 4 Is Stimulated by Mesenchymal Stem Cell Therapy. IJMS 2023;24:5640. [DOI: 10.3390/ijms24065640] [Reference Citation Analysis]
|
| 4 |
Isaković J, Šerer K, Barišić B, Mitrečić D. Mesenchymal stem cell therapy for neurological disorders: The light or the dark side of the force? Front Bioeng Biotechnol 2023;11:1139359. [PMID: 36926687 DOI: 10.3389/fbioe.2023.1139359] [Reference Citation Analysis]
|
| 5 |
Qiu L, Cai Y, Geng Y, Yao X, Wang L, Cao H, Zhang X, Wu Q, Kong D, Ding D, Shi Y, Wang Y, Wu J. Mesenchymal stem cell-derived extracellular vesicles attenuate tPA-induced blood-brain barrier disruption in murine ischemic stroke models. Acta Biomater 2022;154:424-42. [PMID: 36367475 DOI: 10.1016/j.actbio.2022.10.022] [Reference Citation Analysis]
|
| 6 |
Xue T, Wang X, Ru J, Zhang L, Yin H. The inhibitory effect of human umbilical cord mesenchymal stem cells expressing anti-HAAH scFv-sTRAIL fusion protein on glioma. Front Bioeng Biotechnol 2022;10. [DOI: 10.3389/fbioe.2022.997799] [Reference Citation Analysis]
|
| 7 |
Asadi K, Amini A, Gholami A. Mesenchymal stem cell-derived exosomes as a bioinspired nanoscale tool toward next-generation cell-free treatment. Journal of Drug Delivery Science and Technology 2022;77:103856. [DOI: 10.1016/j.jddst.2022.103856] [Reference Citation Analysis]
|
| 8 |
Klimczak A. Mesenchymal Stem/Progenitor Cells and Their Derivates in Tissue Regeneration. Int J Mol Sci 2022;23:6652. [PMID: 35743095 DOI: 10.3390/ijms23126652] [Reference Citation Analysis]
|
| 9 |
Bierhansl L, Hartung HP, Aktas O, Ruck T, Roden M, Meuth SG. Thinking outside the box: non-canonical targets in multiple sclerosis. Nat Rev Drug Discov 2022. [PMID: 35668103 DOI: 10.1038/s41573-022-00477-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Wenceslau CV, de Souza DM, Mambelli-lisboa NC, Ynoue LH, Araldi RP, da Silva JM, Pagani E, Haddad MS, Kerkis I. Restoration of BDNF, DARPP32, and D2R Expression Following Intravenous Infusion of Human Immature Dental Pulp Stem Cells in Huntington’s Disease 3-NP Rat Model. Cells 2022;11:1664. [DOI: 10.3390/cells11101664] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Qin J, Chen J, Peng F, Sun C, Lei Y, Chen G, Li G, Yin Y, Lin Z, Wu L, Li J, Liu W, Peng C, Xie X. Pharmacological activities and pharmacokinetics of liquiritin: A review. J Ethnopharmacol 2022;:115257. [PMID: 35395381 DOI: 10.1016/j.jep.2022.115257] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 12 |
Yarygin KN, Namestnikova DD, Sukhinich KK, Gubskiy IL, Majouga AG, Kholodenko IV. Cell Therapy of Stroke: Do the Intra-Arterially Transplanted Mesenchymal Stem Cells Cross the Blood-Brain Barrier? Cells 2021;10:2997. [PMID: 34831220 DOI: 10.3390/cells10112997] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 13 |
Yudintceva N, Lomert E, Mikhailova N, Tolkunova E, Agadzhanian N, Samochernych K, Multhoff G, Timin G, Ryzhov V, Deriglazov V, Mazur A, Shevtsov M. Targeting Brain Tumors with Mesenchymal Stem Cells in the Experimental Model of the Orthotopic Glioblastoma in Rats. Biomedicines 2021;9:1592. [PMID: 34829821 DOI: 10.3390/biomedicines9111592] [Reference Citation Analysis]
|
